ZA907431B - Oral anticoagulant/platelet inhibitor low dose formulation - Google Patents

Oral anticoagulant/platelet inhibitor low dose formulation

Info

Publication number
ZA907431B
ZA907431B ZA907431A ZA907431A ZA907431B ZA 907431 B ZA907431 B ZA 907431B ZA 907431 A ZA907431 A ZA 907431A ZA 907431 A ZA907431 A ZA 907431A ZA 907431 B ZA907431 B ZA 907431B
Authority
ZA
South Africa
Prior art keywords
oral anticoagulant
low dose
dose formulation
platelet inhibitor
inhibitor low
Prior art date
Application number
ZA907431A
Other languages
English (en)
Inventor
William Joseph Addicks
Joseph Addicks William
Joseph A Mollica
A Mollica Joseph
Gary Howard Slatko
Howard Slatko Gary
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of ZA907431B publication Critical patent/ZA907431B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
ZA907431A 1989-09-18 1990-09-18 Oral anticoagulant/platelet inhibitor low dose formulation ZA907431B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/408,394 US5041430A (en) 1989-09-18 1989-09-18 Oral anticoagulant/platelet inhibitor low dose formulation

Publications (1)

Publication Number Publication Date
ZA907431B true ZA907431B (en) 1992-05-27

Family

ID=23616120

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907431A ZA907431B (en) 1989-09-18 1990-09-18 Oral anticoagulant/platelet inhibitor low dose formulation

Country Status (22)

Country Link
US (1) US5041430A (xx)
EP (1) EP0493408B1 (xx)
JP (1) JPH05501109A (xx)
KR (1) KR950008307B1 (xx)
AT (1) ATE137972T1 (xx)
AU (1) AU635881B2 (xx)
CA (1) CA2065347A1 (xx)
CZ (1) CZ454090A3 (xx)
DE (1) DE69027036D1 (xx)
FI (1) FI921134A (xx)
GR (1) GR1001131B (xx)
HU (1) HUT62488A (xx)
IE (1) IE903356A1 (xx)
IL (1) IL95721A (xx)
LV (1) LV10050B (xx)
MA (1) MA21953A1 (xx)
MX (1) MX173727B (xx)
NO (1) NO920946D0 (xx)
NZ (1) NZ235337A (xx)
PT (1) PT95343B (xx)
WO (1) WO1991004031A1 (xx)
ZA (1) ZA907431B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
CA2100836C (en) * 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
AU5787996A (en) * 1995-04-19 1996-11-07 Lipoprotein Technologies, Inc. Compositions, kits, and methods for administration of antilipemic and anti-platelet aggregation drugs
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
AU2002226986A1 (en) * 2000-12-01 2002-06-11 Rheologics, Inc. In vivo delivery methods and compositions
AU2002306461A1 (en) * 2001-03-28 2002-10-15 Rheologics, Inc. In vivo delivery methods and compositions
AU2003220022A1 (en) * 2002-03-01 2003-09-16 Trustees Of Dartmouth College Compositions and methods for preventing sporadic neoplasia in colon
CA2512666A1 (en) * 2003-01-08 2004-07-29 Flacco-Nesselroad Family Trust Combination therapy for anticoagulation
CZ20032854A3 (cs) * 2003-10-17 2005-05-18 Pliva - Lachema A.S. Způsob přípravy dávkových jednotek pevné lékové formy obsahujících jako účinnou látku sodnou sůl warfarinu
KR20080109101A (ko) * 2003-10-20 2008-12-16 테바 파마슈티컬 인더스트리즈 리미티드 레보도파의 지속적 효과를 위한 조성물 및 제형
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
US8158148B2 (en) * 2004-05-21 2012-04-17 Accu-Break Technologies, Inc. Pharmaceutical tablets comprising two or more unitary segments
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US20060003000A1 (en) * 2004-07-01 2006-01-05 Lawrence Solomon Adhesively bonded dosage form
US8057820B2 (en) * 2004-10-08 2011-11-15 Mcneil-Ppc, Inc. Enteric coated aspirin granules comingled with binder
US8758814B2 (en) 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
JP4613590B2 (ja) 2004-11-16 2011-01-19 セイコーエプソン株式会社 実装基板及び電子機器
WO2008082542A1 (en) * 2006-12-19 2008-07-10 Institute For Therapeutic Research, Inc. Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy
WO2008156691A1 (en) * 2007-06-19 2008-12-24 Duke University Anitcoagulants as antifouling agents
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
JP5529404B2 (ja) * 2008-09-05 2014-06-25 東和薬品株式会社 アスピリン腸溶錠
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
LV14606B (lv) 2011-05-17 2013-01-20 Tetra, Sia Jauns XII faktora inhibitors
CZ2012435A3 (cs) * 2012-06-27 2013-11-13 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta Zpusob prípravy pevné lékové formy se sodnou solí warfarinu ve forme klathrátu izopropanolu
JP6304751B2 (ja) * 2014-03-24 2018-04-04 日新製薬株式会社 ワルファリン含有固形製剤及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2265273A1 (en) * 1974-03-29 1975-10-24 Zootherap Laboratoires Anticoagulant-contg. rodenticidal compsn. - contg. (acetyl) salicyclic acid or salt as synergist
LU77353A1 (xx) * 1977-05-16 1979-01-19
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
DE2860430D1 (en) * 1977-10-08 1981-02-26 Beecham Group Ltd Antithrombotic compositions containing benzisothiazolones
SU1050708A1 (ru) * 1981-04-27 1983-10-30 Горьковский государственный медицинский институт им.С.М.Кирова Способ лечени гиперкоагул ции при коронарном атеросклерозе
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
EP0169465B1 (de) * 1984-07-21 1990-02-28 Hoechst Aktiengesellschaft Kombinationspräparat aus Pyrimido-pyrimidinen und O-Acetylsalicylsäure bzw. deren pharmakologisch verträglichen Salzen und dessen Verwendung

Also Published As

Publication number Publication date
AU635881B2 (en) 1993-04-01
MA21953A1 (fr) 1991-04-01
US5041430A (en) 1991-08-20
IE903356A1 (en) 1991-04-10
PT95343B (pt) 1998-06-30
GR900100702A (en) 1992-01-20
MX173727B (es) 1994-03-24
CZ454090A3 (en) 1996-11-13
NZ235337A (en) 1993-05-26
LV10050A (lv) 1994-05-10
EP0493408A4 (en) 1992-10-07
NO920946L (no) 1992-03-11
EP0493408B1 (en) 1996-05-15
WO1991004031A1 (en) 1991-04-04
PT95343A (pt) 1991-08-14
FI921134A0 (fi) 1992-03-17
EP0493408A1 (en) 1992-07-08
IL95721A0 (en) 1991-06-30
ATE137972T1 (de) 1996-06-15
DE69027036D1 (de) 1996-06-20
KR920703046A (ko) 1992-12-17
JPH05501109A (ja) 1993-03-04
FI921134A (fi) 1992-03-17
LV10050B (en) 1995-02-20
HUT62488A (en) 1993-05-28
KR950008307B1 (ko) 1995-07-27
IL95721A (en) 1995-07-31
GR1001131B (el) 1993-04-28
AU6330690A (en) 1991-04-18
CA2065347A1 (en) 1991-03-19
NO920946D0 (no) 1992-03-11

Similar Documents

Publication Publication Date Title
IL95721A0 (en) Oral anticoagulant/platelet inhibitor low dose formulation
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
MX9202546A (es) Dimeros de rapamicina y composicion farmaceutica que los contiene.
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
NO900439D0 (no) Fremgangsmaate for behandling av uorganisk pulver.
NO912548D0 (no) Fremgangsmaate for behandling av avfallsprodukter.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
IL95849A0 (en) Pharmaceutical combination containing acetylsalicylic acid and carbacyclin derivatives
NO894158D0 (no) Curcumin ved paavisning av varsling av cyanid-oppblandete naeringsmidler.
ES556806A0 (es) Un procedimiento para la preparacion de una composicion preventiva de la elastosis.
NO901422D0 (no) Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer.
FR2707455B1 (fr) Empêchement de la reproduction des insectes xylophages, moyens pour le traitement préventif du matériau bois mis en Óoeuvre.
AR240016A1 (es) Procedimiento de preparacion de una composicion para el tratamiento de flebectasias.
NO885472D0 (no) Fremgangsmaate for belegging av gjenstander av staal.
AR240472Q (es) Un procedimiento para la preparaciond e una composicon lubricante de derivados carboxilicos.
ES1024974Y (es) Contenedor para la conservacion fisiologica temporal de piezas dentarias.
KR920700037A (ko) 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물
ZA892724B (en) N-alkylamino derivatives of aromatic,tricyclic compounds in the treatment of drug-resistant protozoan infections
ES1016142Y (es) Pequeno aparato electrodomestico para la elaboracion de comidas.
IT218494Z2 (it) Sterilizza scarpe